Type 1 diabetes (T1D) is estimated to affect 100,000 children every year worldwide. There were nine million T1D patients in the world in 2017. T1D patients need to monitor blood glucose levels regularly and administrate insulin to manage their blood glucose levels. Moreover, new immunotherapies, personalized gene and stem cell therapies, and non-immunomodulatory adjunctive are being developed to manage T1D.
To gain detailed insights into the latest trends in T1D management, join reputed Diabetologists and Endocrinologists in our exclusive webinar on 23 rd November , 3:00 PM IST onwards . Stay tuned! Suggested for you USFDA Approves First Cellular Therapy for T1D A Case of Insulin Resistance in an Elderly Woman with Type 1 Diabetes (Case Challenge) Diabetes Mellitus Type 1 Management in Children, Adolescents, and Adults: ICMR Guidelines, 2022 ##Disclaimer## The content provided…
